Toronto Joint Department of Medical Imaging, University Health Network, Sinai Health System and Women's College Hospitals, University of Toronto, Toronto, Canada.
Department of Pathology, University Health Network, University of Toronto, Toronto, Canada.
Cancer Imaging. 2018 Feb 27;18(1):8. doi: 10.1186/s40644-018-0142-z.
Combined hepatocellular-cholangiocarcinoma (cHCC-CC) is a rare primary liver tumor, which has overlapping imaging features with mass forming intra-hepatic cholangiocarcinoma (ICC) and hepatocellular carcinoma (HCC). Previous studies reported imaging features more closely resemble ICC and the aim of our study was to examine the differential MRI features of cHCC-CC and ICC with emphasis on enhancement pattern observations of gadolinium enhanced MRI.
Institutional review board approval with consent waiver was obtained for this retrospective bi-centric study. Thirty-three patients with pathologically proven cHCC-CC and thirty-eight patients with pathologically proven ICC, who had pre-operative MRI, were identified. MRI images were analyzed for tumor location and size, T1 and T2 signal characteristics, the presence/absence of: cirrhosis, intra-lesional fat, hemorrhage/hemosiderin, scar, capsular retraction, tumor thrombus, biliary dilatation, degree of arterial enhancement, enhancement pattern, pseudocapsule and washout. Associations between MRI features and tumor type were examined using the Fisher's exact and chi-square tests.
Strong arterial phase enhancement and the presence of: washout, washout and progression, intra-lesional fat and hemorrhage were all strongly associated with cHCC-CC (P < 0.001). While cHCC-CC had a varied enhancement pattern, the two most common enhancement patterns were peripheral persistent (n = 6) and heterogeneous hyperenhancement with washout (n = 6), compared to ICC where the most common enhancement patterns were peripheral hypoenhancement with progression (n = 18) followed by heterogeneous hypoenhancement with progression (n = 14) (P < 0.001).
The cHCC-CC enhancement pattern seems to more closely resemble HCC with the degree of arterial hyperenhancement and the presence of washout being valuable in differentiating cHCC-CC from ICC. However the presence of washout and progression, in the same lesion or a predominantly peripheral /rim hyperenhancing mass were also seen as important features that should alert the radiologist to the possibility of a cHCC-CC.
混合细胞型肝癌(cHCC-CC)是一种罕见的原发性肝癌,其影像学特征与肿块型肝内胆管细胞癌(ICC)和肝细胞癌(HCC)重叠。先前的研究报告称,其影像学特征更类似于 ICC,本研究的目的是检查 cHCC-CC 和 ICC 的 MRI 特征差异,重点是观察钆增强 MRI 的增强模式。
本回顾性双中心研究获得了机构审查委员会的批准并豁免了同意。确定了 33 例经病理证实的 cHCC-CC 患者和 38 例经病理证实的 ICC 患者,这些患者均有术前 MRI。分析了 MRI 图像的肿瘤位置和大小、T1 和 T2 信号特征、是否存在:肝硬化、瘤内脂肪、出血/含铁血黄素、瘢痕、包膜回缩、肿瘤血栓、胆管扩张、动脉期强化程度、强化模式、假包膜和廓清。使用 Fisher 精确检验和卡方检验检查 MRI 特征与肿瘤类型之间的关系。
强烈的动脉期强化和存在廓清、廓清和进展、瘤内脂肪和出血与 cHCC-CC 强烈相关(P < 0.001)。虽然 cHCC-CC 的强化模式多样,但最常见的两种强化模式是外周持续强化(n = 6)和异质性强化伴廓清(n = 6),而 ICC 中最常见的强化模式是外周低强化伴进展(n = 18),其次是异质性低强化伴进展(n = 14)(P < 0.001)。
cHCC-CC 的强化模式似乎更类似于 HCC,动脉期强化程度和廓清的存在有助于将 cHCC-CC 与 ICC 区分开来。然而,在同一病灶或主要为外周/边缘高强化肿块中出现廓清和进展,也被认为是重要的特征,应提醒放射科医生注意可能为 cHCC-CC。